Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells
- 15 June 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (12), 5133-5141
- https://doi.org/10.1158/0008-5472.can-09-0854
Abstract
The mucin 1 (MUC1) oncoprotein is aberrantly overexpressed by ∼90% of human breast cancers. However, there are no effective agents that directly inhibit MUC1 and induce death of breast cancer cells. We have synthesized a MUC1 inhibitor (called GO-201) that binds to the MUC1 cytoplasmic domain and blocks the formation of MUC1 oligomers in cells. GO-201, and not an altered version, attenuates targeting of MUC1 to the nucleus of human breast cancer cells, disrupts redox balance, and activates the DNA damage response. GO-201 also arrests growth and induces necrotic death. By contrast, the MUC1 inhibitor has no effect on cells null for MUC1 expression or nonmalignant mammary epithelial cells. Administration of GO-201 to nude mice bearing human breast tumor xenografts was associated with loss of tumorigenicity and extensive necrosis, which results in prolonged regression of tumor growth. These findings show that targeting the MUC1 oncoprotein is effective in inducing death of human breast cancer cells in vitro and in tumor models. [Cancer Res 2009;69(12):5133–41]Keywords
Other Versions
This publication has 39 references indexed in Scilit:
- MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatmentProceedings of the National Academy of Sciences, 2009
- MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung CancerCancer Research, 2009
- Intracellular MUC1 Peptides Inhibit Cancer ProgressionClinical Cancer Research, 2008
- The Roles of Therapy-Induced Autophagy and Necrosis in Cancer TreatmentClinical Cancer Research, 2007
- MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damageThe EMBO Journal, 2006
- Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucinNature Structural & Molecular Biology, 2005
- MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90Oncogene, 2005
- The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 FibroblastsJournal of Biological Chemistry, 2004
- Human DF3/MUC1 carcinoma-associated protein functions as an oncogeneOncogene, 2003
- Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative StressJournal of Biological Chemistry, 2003